Vingerhagen S, Hausken T, Gilja O H, Berstad A
Medical Department A, Haukeland Hospital, University of Bergen, Bergen, Norway.
Neurogastroenterol Motil. 2000 Feb;12(1):95-101. doi: 10.1046/j.1365-2982.2000.00184.x.
Sumatriptan, a 5HT1 receptor agonist, inhibits antral motor activity, delays gastric emptying and relaxes the gastric fundus. The aim of this study was to characterize the effect of sumatriptan on transpyloric flow and gastric accommodation during and immediately after ingestion of a liquid meal using duplex sonography. Ten healthy subjects were investigated twice on separate days. In random order either sumatriptan 6 mg (Imigran 0.5 mL) or a placebo were given s.c. 15 min before ingesting 500 mL of a meat soup. The subjects were examined during the 3-min period before ingestion of the liquid meal, the 3-min spent drinking the meal and 10 min postprandially. Sumatriptan caused a significant widening of both the gastric antrum (P=0.02) and the proximal stomach (P=0.01) 10 min postprandially as compared with placebo. It caused no significant differences in time to initial gastric emptying (P=0.2), but significantly delayed commencement of peristaltic-related transpyloric flow (P=0.04). Sumatriptan had no significant effect on mean abdominal symptom scores, but after sumatriptan there was a significant negative correlation between width of postprandial antral area and postprandial nausea and between width of postprandial antral area and postprandial bloating. We therefore conclude that sumatriptan causes a postprandial dilatation of both the distal and the proximal stomach with no change in dyspeptic symptoms nor in length of time to first gastric emptying. Time to commencement of peristaltic-related emptying is delayed.
舒马曲坦是一种5-羟色胺1(5HT1)受体激动剂,可抑制胃窦运动活性、延缓胃排空并使胃底松弛。本研究的目的是利用双功超声检查法,明确舒马曲坦对摄入流食期间及刚摄入后经幽门的血流和胃容纳功能的影响。10名健康受试者在不同日期接受了两次检查。随机顺序在摄入500毫升肉汤前15分钟皮下注射6毫克舒马曲坦(英明格0.5毫升)或安慰剂。在摄入流食前3分钟、饮用流食的3分钟以及餐后10分钟对受试者进行检查。与安慰剂相比,舒马曲坦在餐后10分钟使胃窦(P=0.02)和胃近端(P=0.01)均显著增宽。在初始胃排空时间方面无显著差异(P=0.2),但与蠕动相关的经幽门血流开始时间显著延迟(P=0.04)。舒马曲坦对平均腹部症状评分无显著影响,但使用舒马曲坦后,餐后胃窦面积宽度与餐后恶心以及餐后胃窦面积宽度与餐后腹胀之间存在显著负相关。因此,我们得出结论,舒马曲坦导致餐后胃远端和近端均扩张,消化不良症状及首次胃排空时间均无变化。与蠕动相关的排空开始时间延迟。